https://14546.iqanda-cme.com/ 2021-04-29T17:59:00+0000 weekly 1 https://14546.iqanda-cme.com/about-thyroid-hormone-replacement 2023-10-25T19:28:32+0000 weekly 0.8 https://14546.iqanda-cme.com/thyroid-hormone-replacement 2024-12-17T18:56:28+0000 weekly 0.8 https://14546.iqanda-cme.com/thyroid-hormone-replacement-resources 2021-05-10T19:43:24+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/how-do-you-evaluate-the-success-of-combination-therapy-what-laboratory-and/or-symptom-parameters-do-you-assess-and-how-do-you-initiate-combination-therapy-with-synthetic-t4-and-t3 2024-11-25T20:31:40+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/what-is-the-role-of-the-thyroid-ultrasound-in-patients-being-evaluated-for-hypothyroidism-and-why-is-confirming-the-diagnosis-critical-prior-to-initiating-therapy 2022-07-26T00:35:58+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/once-you-ve-determined-that-lt4-therapy-is-not-achieving-the-desired-symptomatic-end-points-what-are-the-practical-aspects-of-initiating-dte-therapy-in-the-pcp-setting-what-does-the-dte-roadmap-look-like-for-np-thyroid-and-other-dte-form 2022-07-26T00:24:15+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/in-addition-to-recognizing-subtle-clinical-signs-of-hypothyroidism-fatigue-decreased-energy-and-other-non-specific-findings-what-are-the-guideline-consistent-benchmarks-for-laboratory-evaluation-of-a-person-suspected-of-having-hypothyroi 2022-07-26T00:36:25+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/how-will-patients-with-hypothyroidism-typically-present-to-clinical-care-providers-what-are-the-guideline-endorsed-protocols-for-laboratory-evaluation-and-how-do-we-confirm-our-treatment-strategy-has-been-successful-from-the-patient-pers 2022-07-26T00:26:02+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/what-is-the-alternative-to-using-monotherapy-with-levothyroxine-and-what-role-has-dessicated-thyroid-extract-dte-played-historically-in-treating-hypothyroidism-and-what-have-we-learned-from-this-experience 2022-07-26T00:34:44+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/in-primary-care/internal-medicine-combination-therapy-typically-consists-of-dte-as-the-preferred-approach-in-patients-failing-to-respond-to-lt4-monotherapy-can-you-provide-a-roadmap-for-dte-use-including-np-thyroid-and-other-formulations 2022-07-26T00:30:09+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/how-is-laboratory-monitoring-of-persons-on-lt4-therapy-different-from-patients-who-are-taking-combination-therapy-with-a-dte-do-you-need-to-monitor-t3-in-patients-on-dte-what-should-you-be-observing-with-respect-to-symptomatic-improvemen 2022-07-26T00:24:02+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/can-you-review-current-ata-consistent-guidelines-for-specific-thyroid-replacement-formulations-initially-recommended-in-newly-diagnosed-persons-with-hypothyroidism-why-is-t4-levothyroxine-alone-usually-recommended-as-opposed-to-combinati 2022-07-26T00:34:57+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/what-is-your-initial-ata-guidelines-sanctioned-approach-to-therapy-for-hypothyroidism-and-when-might-this-initial-strategy-require-modification-how-focused-should-we-be-on-squaring-the-numbers-tsh-and-t4-and/or-t3-as-a-benchmark-for-succ 2022-07-26T00:25:47+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/can-you-discuss-the-importance-of-screening-diagnosis-and-assessment-of-hypothyroidism-what-is-the-unique-metabolic-role-and-impact-of-t3-on-target-organs-especially-the-cardiovascular-system-and-cns 2024-12-20T04:10:34+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/although-guidelines-indicate-that-normalization-of-tsh-and-thyroid-hormone-levels-is-an-important-goal-confirming-successful-treatment-with-hormone-replacement-is-this-the-optimal-approach-and/or-the-singular-criterion-clinicians-should- 2022-07-26T00:35:28+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/is-it-preferable-to-use-dte-as-a-stand-alone-combination-therapy-to-substitute-for-lt4-or-can/should-it-be-used-to-supplement-lt4-monotherapy-and-what-is-the-safety-profile-of-dte-and-what-is-the-monitoring-strategy-for-combination-thera 2022-07-26T00:28:32+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/once-we-decide-to-treat-a-patient-with-laboratory-findings-and-a-clinical-presentation-compatible-with-hypothyroidism-how-do-we-initiate-treatment-with-synthetic-lt4-how-do-we-monitor-with-respect-to-lt4-t3-tsh-and-their-global-health 2022-07-26T00:31:37+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/what-is-your-approach-to-persons-who-have-a-tsh-level-between-4-5-and-10-do-they-all-get-treated-or-are-there-other-stratification-criteria-i-e-the-presence-of-antithyroid-antibodies-you-use-to-determine-the-need-for-thyroid-hormone-ther 2022-07-26T00:36:11+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/once-you-begin-thyroid-hormone-replacement-therapy-how-is-that-patient-followed-clinically-to-ensure-treatment-success-what-are-the-recommended-starting-doses-how-do-you-titrate-the-dose-over-time 2022-07-26T00:34:32+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/can-you-summarize-the-current-role-of-dte-in-managing-persons-with-hypothyroidism-and-the-approach-to-identifying-the-10-20-of-persons-on-lt4-monotherapy-who-because-of-symptomatic-shortfalls-may-be-appropriate-for-combination-therapy 2022-07-26T00:23:48+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/once-you-decide-to-treat-in-order-to-address-the-full-treatment-outcome-equation-that-is-achieving-both-laboratory-tsh-t4-targets-and-symptomatic/quality-of-life-goals-how-do-you-construct-your-therapeutic-regimen 2022-07-26T00:25:27+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/can-you-give-clinicians-a-sense-of-how-many-people-treated-for-hypothyroidism-with-t4-monotherapy-fall-into-a-less-than-optimal-outcome-category-and-should-be-considered-for-combination-approaches-including-those-that-might-include-dte 2022-07-26T00:33:48+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/what-percentage-of-patients-who-for-symptomatic-reasons-have-been-switched-from-lt4-monotherapy-to-dte-do-you-find-actually-improve-on-dte-and-what-do-they-report 2022-07-26T00:27:24+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/when-using-lt4-monotherapy-is-monitoring-of-tsh-sufficient-to-guide-therapy-can-you-elaborate-on-this 2022-07-26T00:31:26+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/there-is-a-subset-of-patients-who-don-t-respond-to-or-are-dissatisfied-with-levothyroxine-t4-monotherapy-what-percentage-don-t-respond-to-conventional-therapy-why-is-combination-therapy-with-t3/t4-considered-appropriate-for-this-group 2022-07-26T00:34:04+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/under-what-circumstances-would-a-clinician-consider-deploying-combination-t4/t3-therapy-whether-adding-on-synthetic-t3-to-t4-or-considering-dessicated-thyroid-extract-dte-how-do-you-identify-patients-who-are-appropriate-for-combination-t 2022-07-26T00:25:06+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/how-would-you-summarize-your-experience-with-hypothyroidism-in-particular-your-perspective-on-the-current-role-of-combination-therapy-with-dte 2022-07-26T00:27:07+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/can-you-discuss-the-consensus-report-on-identifying-a-subset-of-patients-with-hypothyroidism-who-fail-to-achieve-optimal-symptomatic-resolution-with-lt4-monotherapy-and-therefore-should-be-considered-for-combination-t4/t3-combination-the 2022-07-26T00:26:34+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/once-you-commit-a-person-with-hypothyroidism-to-combination-therapy-with-t4/t3-how-do-you-follow-the-patient-what-have-you-observed-as-far-as-improvements-in-patient-status-and/or-their-perceptions-about-the-effects-of-combination-t4/t3- 2022-07-26T00:32:57+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/what-is-your-approach-to-the-patient-who-has-a-tsh-of-2-5-well-within-the-normal-range-but-the-patient-still-has-symptoms-is-there-a-rationale-for-bringing-the-tsh-down-to-let-s-say-1-0-or-0-7-that-is-to-a-lower-level-within-the-normal-r 2022-07-26T00:35:10+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/what-is-causing-the-presence-of-10-15-of-patients-with-hypothyroidism-who-are-dissatisfied-with-levothyroxine-monotherapy-what-is-the-role-of-t3-as-a-causative-factor-and-what-are-the-implications-for-combination-therapy-and/or-dte 2022-07-26T00:33:35+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/how-does-the-peripheral-metabolism-the-conversion-or-compromised-conversion-of-t4-to-t3-affect-a-patient-s-response-to-t4-monotherapy-how-does-that-set-the-stage-for-combination-t4-plus-t3-therapy-in-appropriately-selected-patients 2022-07-26T00:24:51+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/the-recognition-that-lt4-monotherapy-is-inadequate-for-producing-symptomatic-improvement-in-many-patients-has-led-to-the-formation-of-an-international-working-group-focused-on-identifying-such-patients-can-you-share-your-experience-with- 2022-07-26T00:30:54+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/can-you-summarize-the-current-treatment-challenges-for-hypothyroidism-as-encountered-by-a-broad-spectrum-of-clinicians-including-primary-care-internal-medicine-endocrine-women-s-health-and-geriatric-specialists 2022-07-26T00:32:02+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/what-practical-advice-would-you-give-to-physicians-who-are-not-familiar-with-the-specifics-of-how-to-initiate-and/or-monitor-therapy-with-dte-are-conversion-tables-available-is-there-data-to-suggest-which-approach-is-better-dte-or-t4/t3- 2022-07-26T00:32:29+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/from-a-front-lines-clinical-perspective-what-does-the-treatment-roadmap-for-combination-t3/t4-therapy-look-like-what-approach-to-combination-therapy-do-you-recommend-for-the-primary-care-internal-medicine-and/or-women-s-health-specialist 2022-07-26T00:32:43+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/what-laboratory-and/or-clinical-features-especially-persistent-symptoms-suggest-the-need-for-combination-therapy-including-with-a-dte-to-optimize-management-what-have-trials-evaluating-patient-preferences-suggested-about-combination-ther 2022-07-26T00:30:40+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/once-you-decide-on-combination-therapy-what-are-the-practical-strategies-specifically-approved-drug-formulations-whether-it-be-synthetic-t3-cytomel-or-dte-that-clinicians-should-consider-at-the-front-lines-of-care-for-hypothyroidism 2022-07-26T00:24:37+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/can-you-walk-us-through-the-typical-presentation-of-a-patient-with-hypothyroidism-and-what-the-guideline-adherent-approach-is-to-laboratory-evaluation-clinical-decision-tree-and-initiation-of-therapy 2022-07-26T00:31:50+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/do-you-recommend-measuring-t3-levels-in-patients-who-are-not-satisfied-with-or-symptomatically-burdened-after-being-launched-on-t4-what-factors-support-a-decision-to-embark-on-combination-t4/t3-therapy-either-by-adding-t3-or-treating-wit 2022-07-26T00:33:10+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/how-do-you-measure-clinical-success-in-persons-started-on-thyroid-replacement-therapy-what-balance-are-you-looking-to-strike-in-a-treatment-outcome-as-it-relates-to-improved-laboratory-findings-and-improved-patient-well-being-and-quality 2022-07-26T00:35:44+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/among-patients-who-are-started-on-combination-therapy-with-dte-or-add-on-t3-what-do-your-patients-report-what-is-the-trial-based-evidence-that-supports-use-of-dte-in-a-selected-group-of-patients-failing-to-respond-optimally-to-t4 2022-07-26T00:32:13+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/can-you-summarize-the-epidemiology-evaluation-quality-of-life-issues-and-treatment-challenges-for-hypothyroidism-encountered-by-clinicians-including-primary-care-internal-medicine-endocrine-women-s-health-and-geriatric-specialists 2022-07-26T00:36:41+0000 weekly 0.8 https://14546.iqanda-cme.com/videos/what-is-the-composition-of-dessicated-thyroid-extract-dte-and-what-makes-it-potentially-useful-in-patients-who-have-has-suboptimal-response-to-lt4-monotherapy-what-properties-are-shared-by-available-dte-preparations-np-thyroid-and-armour 2022-07-26T00:26:50+0000 weekly 0.8 https://14546.iqanda-cme.com/courses/focus-on-the-role-rationale-evidence-and-practical-application-of-combination-therapy-with-dte-in-appropriately-selected-patients 2023-10-25T19:29:20+0000 weekly 0.8